a public good project by the
Synthesis
Company
of California

© 2026

Feng Jung Sherida H. Woei-A-Jin | doi.page

0 works0 citations0 h-index

Feng Jung Sherida H. Woei-A-Jin

Rega Institute for Medical Research(BE)Universitair Ziekenhuis Leuven(BE)KU Leuven(BE)

Publications by Year

Research Areas

Lymphoma Diagnosis and Treatment, Ubiquitin and proteasome pathways, Cutaneous lymphoproliferative disorders research, Cytokine Signaling Pathways and Interactions, Chronic Lymphocytic Leukemia Research

Most-Cited Works

→ The PROCLIPI international registry of early‐stage mycosis fungoides identifies substantial diagnostic delay in most patients(2018)221 cited
→ ALK-positive histiocytosis: a new clinicopathologic spectrum highlighting neurologic involvement and responses to ALK inhibition(2021)146 cited
→ Characteristics associated with significantly worse quality of life in mycosis fungoides/Sézary syndrome from the Prospective Cutaneous Lymphoma International Prognostic Index ( PROCLIPI ) study(2019)106 cited
→ Case Report: VEXAS Syndrome: From Mild Symptoms to Life-Threatening Macrophage Activation Syndrome(2021)99 cited
→ Tissue factor-bearing microparticles and CA19.9: two players in pancreatic cancer-associated thrombosis?(2016)76 cited
→ Impact of etoposide and ASCT on survival among patients aged &lt;65 years with stage II to IV PTCL: a population-based cohort study(2022)68 cited

→ Convalescent plasma treatment of persistent severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) infection in patients with lymphoma with impaired humoral immunity and lack of neutralising antibodies(2020)

60 cited

→ Obstetric and maternal outcomes in patients diagnosed with Hodgkin lymphoma during pregnancy: a multicentre, retrospective, cohort study(2019)60 cited

→ Incidence of osteonecrosis of the jaw in patients with bone metastases treated sequentially with bisphosphonates and denosumab(2017)59 cited

→ Incidence of medication-related osteonecrosis of the jaw in patients treated with both bone resorption inhibitors and vascular endothelial growth factor receptor tyrosine kinase inhibitors(2017)58 cited